| scholarly article | Q13442814 |
| P50 | author | Ana González-Pinto | Q56995383 |
| Julio Bobes | Q61314210 | ||
| Maria Paz Garcia-Portilla | Q88565069 | ||
| Alessandra M A Nivoli | Q117224679 | ||
| Eduard Vieta | Q20090640 | ||
| Andrea Murru | Q42839770 | ||
| P2093 | author name string | José M Crespo | |
| José M Montes | |||
| José M Goikolea | |||
| Jerónimo Sáiz-Ruiz | |||
| P433 | issue | 2 | |
| P304 | page(s) | 125-141 | |
| P577 | publication date | 2011-11-17 | |
| P1433 | published in | Journal of Affective Disorders | Q15716493 |
| P1476 | title | New treatment guidelines for acute bipolar mania: a critical review | |
| P478 | volume | 140 |
| Q24201765 | Aripiprazole alone or in combination for acute mania |
| Q26800235 | Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice |
| Q43618621 | Clinical management and burden of bipolar disorder: results from a multinational longitudinal study (WAVE-bd). |
| Q34308027 | Combination therapy for manic phases: a critical review of a common practice |
| Q38076126 | Drug treatment developments in schizophrenia and bipolar mania: latest evidence and clinical usefulness |
| Q34504406 | European Network of Bipolar Research Expert Centre (ENBREC): a network to foster research and promote innovative care |
| Q46300154 | Guidelines for the recognition and management of mixed depression |
| Q36568973 | How assess drugs in the treatment of acute bipolar mania? |
| Q91302159 | Intervening early in bipolar disorder in young people: a review of the clinical staging model |
| Q36319067 | Lithium in late-life mania: a systematic review |
| Q38530476 | Management of adverse effects of mood stabilizers |
| Q44403456 | Modulation of neuronal plasticity following chronic concomitant administration of the novel antipsychotic lurasidone with the mood stabilizer valproic acid |
| Q47242174 | Omega-3 fatty acids supplementation with lithium and aripiprazole for improving the balance of circulating hormones and brain neurotransmitters in manic mice model |
| Q34636572 | Patterns of initiation of second generation antipsychotics for bipolar disorder: a month-by-month analysis of provider behavior |
| Q34374891 | Pharmaco-utilisation and related costs of drugs used to treat schizophrenia and bipolar disorder in Italy: the IBIS study |
| Q38364834 | Pharmacotherapy of acute mania: monotherapy or combination therapy with mood stabilizers and antipsychotics? |
| Q35862776 | Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders |
| Q46122791 | Side effects associated with psychotropic medications in patients with bipolar disorder: evidence from two independent samples |
| Q28066714 | The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm |
| Q50654393 | The bipolar maze: a roadmap through translational psychopathology. |
| Q38120295 | The preclinical profile of lurasidone: clinical relevance for the treatment of schizophrenia. |
| Q34823805 | Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges |
| Q37138425 | What goes up must come down: the burden of bipolar depression in youth |
Search more.